statistiche ricercatore

Nazione	#
US - Stati Uniti d'America	941
SG - Singapore	102
CN - Cina	78
HK - Hong Kong	43
BR - Brasile	27
FI - Finlandia	21
IT - Italia	17
DE - Germania	16
NL - Olanda	14
RU - Federazione Russa	10
UA - Ucraina	10
IN - India	8
FR - Francia	7
GB - Regno Unito	7
AT - Austria	6
SE - Svezia	6
VN - Vietnam	6
CA - Canada	5
PL - Polonia	5
BD - Bangladesh	4
ES - Italia	4
IE - Irlanda	4
JP - Giappone	4
BZ - Belize	3
HU - Ungheria	3
IQ - Iraq	3
MW - Malawi	3
UZ - Uzbekistan	3
AR - Argentina	2
AU - Australia	2
BE - Belgio	2
BY - Bielorussia	2
CO - Colombia	2
DO - Repubblica Dominicana	2
EC - Ecuador	2
GN - Guinea	2
GP - Guadalupe	2
JM - Giamaica	2
LT - Lituania	2
MX - Messico	2
NG - Nigeria	2
NZ - Nuova Zelanda	2
PA - Panama	2
PE - Perù	2
PK - Pakistan	2
SA - Arabia Saudita	2
SI - Slovenia	2
SK - Slovacchia (Repubblica Slovacca)	2
SN - Senegal	2
TR - Turchia	2
YT - Mayotte	2
ZA - Sudafrica	2
AE - Emirati Arabi Uniti	1
AM - Armenia	1
AO - Angola	1
BA - Bosnia-Erzegovina	1
BF - Burkina Faso	1
BJ - Benin	1
BS - Bahamas	1
BW - Botswana	1
CD - Congo	1
CG - Congo	1
CI - Costa d'Avorio	1
CL - Cile	1
CV - Capo Verde	1
CY - Cipro	1
DJ - Gibuti	1
DK - Danimarca	1
DZ - Algeria	1
GA - Gabon	1
GE - Georgia	1
GF - Guiana Francese	1
GH - Ghana	1
GR - Grecia	1
GT - Guatemala	1
HN - Honduras	1
IR - Iran	1
JO - Giordania	1
KE - Kenya	1
KH - Cambogia	1
KY - Cayman, isole	1
LV - Lettonia	1
LY - Libia	1
MK - Macedonia	1
ML - Mali	1
MY - Malesia	1
NA - Namibia	1
NO - Norvegia	1
PG - Papua Nuova Guinea	1
PY - Paraguay	1
RS - Serbia	1
RW - Ruanda	1
SD - Sudan	1
SO - Somalia	1
SY - Repubblica araba siriana	1
TZ - Tanzania	1
UY - Uruguay	1
ZW - Zimbabwe	1
Totale	1.454

Nome	#
Protein Kinase CK2 Inhibitors: Emerging Anticancer Therapeutic Agents?	139
Designing a ligand for pharmaceutical purposes	131
The perils of dental vacation: possible anaesthetic and medicolegal consequences.	126
BACE1 inhibitory activities of enantiomerically pure, variously substituted N-(3-(4-benzhydrylpiperazin-1-yl)-2-hydroxypropyl) arylsulfonamides	122
ATP Non-Competitive Ser/Thr Kinase Inhibitors as Potential Anticancer Agents	115
The ATP-binding site of protein kinase CK2 holds a positive electrostatic area and conserved water molecules	115
How Druggable Is Protein Kinase CK2?	113
Rational Design of New Protein Kinases Inhibitors of Pharmaceutical Interest	110
In silico binding free energy predictability by using the linear interaction energy (LIE) method: Bromobenzimidazole CK2 inhibitors as a case study	104
Transient abdominal motor block after a transversus abdominis plane block in an elderly patient	103
Coumarin as attractive casein kinase 2(CK2) inhibitor scaffold: an integrated approach to elucidate the putative binding motif and explain structure-activity relationship.	101
Carbazole-containing arylcarboxamides as BACE1 inhibitors.	100
alpha-Naphthylaminopropan-2-ol Derivatives as BACE1 Inhibitors	79
Totale	1.458

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	85	0	0	1	18	3	13	0	13	19	6	9	3
2021/2022	173	0	17	34	17	1	3	6	33	2	2	27	31
2022/2023	164	24	21	4	19	23	32	1	11	24	0	5	0
2023/2024	72	2	18	4	7	5	4	2	9	4	4	9	4
2024/2025	344	1	50	7	19	55	11	19	18	21	7	51	85
2025/2026	140	38	87	15	0	0	0	0	0	0	0	0	0
Totale													1.458